Something happened to change the approach to treatment of infant spittyness over the past decade: H2 blockers and PPIs were introduced into the pharmacological armamentarium of pediatric primary care.
I was chagrined to learn recently that 5% of infants are prescribed medication for GERD—gastroesophageal reflux disease, the latest diagnosis du jour in primary care pediatrics. >>more
Readers can now access my latest essay, Ruminating on GERD, newly published in the Yale Journal for Humanities in Medicine.
